Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas
Kirstie Canene-Adams1, Brian L Lindshield, Shihua Wang
1Division of Nutritional Sciences and Department of Food Science and Human Nutrition, University of Illinois, Urbana, Illinois 61801, and Department of Internal Medicine, James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
Abstract:
The consumption of diets containing 5 to 10 servings of fruits and vegetables daily is the foundation of public health recommendations for cancer prevention, yet this concept has not been tested in experimental models of prostate cancer. We evaluated combinations of tomato and broccoli in the Dunning R3327-H prostate adenocarcinoma model. Male Copenhagen rats (n=206) were fed diets containing 10% tomato, 10% broccoli, 5% tomato plus 5% broccoli (5:5 combination), 10% tomato plus 10% broccoli (10:10 combination) powders, or lycopene (23 or 224 nmol/g diet) for approximately 22 weeks starting 1 month prior to receiving s.c. tumor implants. We compared the effects of diet to surgical castration (2 weeks before termination) or finasteride (5 mg/kg body weight orally, 6 d/wk). Castration reduced prostate weights, tumor areas, and tumor weight (62%, P<0.001), whereas finasteride reduced prostate weights (P<0.0001), but had no effect on tumor area or weight. Lycopene at 23 or 224 nmol/g of the diet insignificantly reduced tumor weights by 7% or 18%, respectively, whereas tomato reduced tumor weight by 34% (P<0.05). Broccoli decreased tumor weights by 42% (P<0.01) whereas the 10:10 combination caused a 52% decrease (P<0.001). Tumor growth reductions were associated with reduced proliferation and increased apoptosis, as quantified by proliferating cell nuclear antigen immunohistochemistry and the ApopTag assay. The combination of tomato and broccoli was more effective at slowing tumor growth than either tomato or broccoli alone and supports the public health recommendations to increase the intake of a variety of plant components.
Insights
Increasing fruit and vegetable intake, like tomato and broccoli, shows promise in slowing prostate cancer growth. A combination diet was more effective than single components, supporting public health recommendations.
Area of Science:
- Oncology
- Nutritional Science
- Cancer Prevention
Background:
- Public health guidelines recommend 5-10 servings of fruits and vegetables daily for cancer prevention.
- The efficacy of these dietary recommendations has not been experimentally validated in prostate cancer models.
Purpose of the Study:
- To investigate the effects of tomato and broccoli consumption, individually and in combination, on prostate cancer growth in an experimental model.
- To compare dietary interventions with established treatments like surgical castration and finasteride.
Main Methods:
- Utilized the Dunning R3327-H prostate adenocarcinoma rat model (n=206).
- Administered diets containing tomato powder, broccoli powder, a 5:5 or 10:10 combination, or lycopene for approximately 22 weeks.
- Compared dietary effects to surgical castration and finasteride treatment, assessing tumor growth, proliferation, and apoptosis.
Main Results:
- Surgical castration significantly reduced tumor weight (62%), while finasteride only reduced prostate weight.
- Tomato alone reduced tumor weight by 34%; broccoli alone reduced it by 42%.
- A 10:10 combination of tomato and broccoli powder significantly decreased tumor weight by 52%, outperforming individual components and lycopene.
Conclusions:
- Combined tomato and broccoli diets are more effective in inhibiting prostate cancer growth than individual components or lycopene.
- Dietary interventions led to reduced tumor cell proliferation and increased apoptosis.
- Findings support public health recommendations for increased intake of diverse plant-based foods for cancer prevention.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer Prevention
Some...
